Abstract:Background: Soft markers are common prenatal ultrasonographic findings that indicate an increased risk for fetal aneuploidy. However, the association between soft markers and pathogenic or likely pathogenic copy number variations is still unclear, and clinicians lack clarity on which soft markers warrant a recommendation for invasive prenatal genetic testing of the fetus. Objective: This study aimed to provide guidance on ordering prenatal genetic testing for fetuses with different soft markers and to elucidate the association between specific types of chromosomal abnormalities and specific ultrasonographic soft markers. Study design: Low-pass genome sequencing was performed for 15,263 fetuses, including 9123 with ultrasonographic soft markers and 6140 with normal ultrasonographic findings. The detection rate of pathogenic or likely pathogenic copy number variants among fetuses with various ultrasonographic soft markers were compared with that of fetuses with normal ultrasonography. The association of soft markers with aneuploidy and pathogenic or likely pathogenic copy number variants were investigated using Fisher exact tests with Bonferroni correction. Results: The detection rate of aneuploidy and pathogenic or likely pathogenic copy number variants was 3.04% (277/9123) and 3.40% (310/9123), respectively, in fetuses with ultrasonographic soft markers. An absent or a hypoplastic nasal bone was the soft marker in the second trimester with the highest diagnostic rate for aneuploidy of 5.22% (83/1591) among all isolated groups. Four types of isolated ultrasonographic soft markers, namely a thickened nuchal fold, single umbilical artery, mild ventriculomegaly, and absent or hypoplastic nasal bone, had higher diagnostic rates for pathogenic or likely pathogenic copy number variants (P<.05; odds ratio, 1.69-3.31). Furthermore, this study found that the 22q11.2 deletion was associated with an aberrant right subclavian artery, whereas the 16p13.11 deletion, 10q26.13-q26.3 deletion, and 8p23.3-p23.1 deletion were associated with a thickened nuchal fold, and the 16p11.2 deletion and 17p11.2 deletion were associated with mild ventriculomegaly (P<.05). Conclusion: Ultrasonographic phenotype-based genetic testing should be considered in clinical consultations. Copy number variant analysis is recommended for fetuses with an isolated thickened nuchal fold, a single umbilical artery, mild ventriculomegaly, and an absent or a hypoplastic nasal bone. A comprehensive definition of genotype-phenotype correlations in aneuploidy and pathogenic or likely pathogenic copy number variants could provide better information for genetic counseling.

Correlation of Sole Prenatal Indication to Fetal Chromosomal Karyotype Abnormality

Analysis of chromosomal karyotypes in 1068 cases of genetic counseling

Predictive Significance of Risk Value in Prenatal Screening for Fetal Trisomy 18

Clinical analysis of 198 cases of fetal anomalies and preventive measures

Clinical Analysis on Prenatal Diagnosis of Amniocentesis in 818 Cases

Association of Maternal Age with Fetal Sex Chromosome Aneuploidies

Prenatal cytogenetic diagnosis study of 1981 cases of advanced pregnant women

Detection Rate of Chromosomal Abnormalities in Women with Different Indications for Invasive Prenatal Diagnosis and Procedure-Related Complications

Amniotic cell karyotyping in pregnant women with a history of abnormal pregnancy

Analysis of chromosomal karyotypes in 119 fetal blood cases during the second and third trimesters of gestation

Ultrasonographically detectable markers of fetal chromosomal abnormalities

Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities

[Prenatal Genetic Study of Fetuses with Congenital Heart Diseases].

Chromosomal Microarray Analysis in Fetuses with High-Risk Prenatal Indications: A Retrospective Study in China.

Association analysis between chromosomal abnormalities and fetal ultrasonographic soft markers based on 15,263 fetuses

Clinical Value and Effectiveness of Sonography Screening for Fetal Chromosomal Abnormalities in the Middle and Late Pregnancy

Association of maternal risk factors with fetal aneuploidy and the accuracy of prenatal aneuploidy screening: a correlation analysis based on 12,186 karyotype reports

Clinical Experience with Fetal Sex Chromosome Aneuploidy Identified by Non-Invasive Prenatal Testing in 45773 Cases

A 10-Year Retrospective Study on Prenatal Cytogenetic Analyses

[Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples]

Chromosomal abnormalities detected by chromosomal microarray analysis and pregnancy outcomes of 4211 fetuses with high-risk prenatal indications